Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001410939-19-000023
Filing Date
2019-04-18
Accepted
2019-04-17 18:24:47
Documents
7
Period of Report
2018-04-18
Effectiveness Date
2019-04-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxystatementfor2019annua.htm DEF 14A 1186684
2 a3yearchart.jpg GRAPHIC 41219
3 ceopaya01.jpg GRAPHIC 122486
4 drgsignaturea01.gif GRAPHIC 2991
5 ivericbio2.jpg GRAPHIC 142773
6 ivericbiocommon_01a01.jpg GRAPHIC 586074
7 ivericbiocommon_02a01.jpg GRAPHIC 656959
  Complete submission text file 0001410939-19-000023.txt   3325290
Mailing Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119
Business Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

EIN.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36080 | Film No.: 19753981
SIC: 2834 Pharmaceutical Preparations